# Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function

> **NCT01961453** · PHASE2 · WITHDRAWN · sponsor: **Corporal Michael J. Crescenz VA Medical Center**

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Isosorbide Mononitrate, sustained release
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT01961453
- **Lead sponsor:** Corporal Michael J. Crescenz VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-08
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding
- **Last updated:** 2016-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01961453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01961453, "Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01961453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*